AJCN Tufts Nutrition Symposium, Boston Sept 24-26
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhou, S. J
Right arrow Articles by Makrides, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, S. J
Right arrow Articles by Makrides, M.
Agricola
Right arrow Articles by Zhou, S. J
Right arrow Articles by Makrides, M.
American Journal of Clinical Nutrition, Vol. 83, No. 5, 1112-1117, May 2006
© 2006 American Society for Nutrition


ORIGINAL RESEARCH COMMUNICATION

Effect of iron supplementation during pregnancy on the intelligence quotient and behavior of children at 4 y of age: long-term follow-up of a randomized controlled trial1,2,3

Shao J Zhou, Robert A Gibson, Caroline A Crowther, Peter Baghurst and Maria Makrides

1 From the Child Nutrition Research Centre and the Department of Pediatrics (SJZ, RAG, and MM), the Department of Obstetrics & Gynaecology (CAC and MM), and the Departments of Paediatrics and Public Health (PB), Women's & Children's Hospital, University of Adelaide, North Adelaide, Australia.

Background: Iron supplements are often prescribed during pregnancy despite the lack of intervention trials that have assessed the effects of supplementation in pregnancy on childhood development.

Objective: The objective was to determine whether iron supplementation during pregnancy influences childhood intelligence quotient (IQ) in an industrialized country.

Design: Pregnant women (n = 430) were randomly allocated to receive iron (20 mg/d) or placebo from 20 wk gestation until delivery, and the women and their children were followed up over the long term (4 y). Seventy percent of these families participated in the follow-up. The proportion of women with iron deficiency anemia at the end of pregnancy was 1% (2 of 146) in the iron group and 11% (15 of 141) in the placebo group. The primary outcome was the IQ of the children at 4 y of age, as assessed by the Stanford-Binet Intelligence Scale. Secondary outcomes included child behavior and the general health of the mothers.

Results: The mean IQ was not significantly different (P = 0.980) between the children of the iron-supplemented mothers (109 ± 11; n = 153) and the children of the mothers in the placebo group (109 ± 11; n = 149). However, the percentage of children with an abnormal behavior score was higher in the iron group (24 of 151, or 16%) than in the placebo group (12 of 149, or 8%); the relative risk was 1.97 (95% CI: 1.03, 3.80; P = 0.037). There was no significant difference in the health of the mothers between groups, as assessed by the SF-36 Health Survey.

Conclusions: Prenatal iron supplementation that reduces the incidence of iron deficiency anemia from 11% to 1% has no effect on the IQ of the offspring at 4 y of age.

Key Words: Iron supplementation • pregnancy • child development • intelligence quotient • IQ • behavior • industrialized country







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by The American Society for Nutrition